These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17652635)

  • 1. Diagnostic pathology and laboratory medicine in the age of "omics": a paper from the 2006 William Beaumont Hospital Symposium on Molecular Pathology.
    Finn WG
    J Mol Diagn; 2007 Sep; 9(4):431-6. PubMed ID: 17652635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: Molecular Medicine in the Common Era: Applications and Impact of Molecular Pathology in Health and Disease.
    Bluth MH
    Clin Lab Med; 2018 Jun; 38(2):209-213. PubMed ID: 29776627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of omics and systems medicine: focus on predictive and individualized treatment.
    Benson M
    J Intern Med; 2016 Mar; 279(3):229-40. PubMed ID: 26891944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of regulatory toxicology: impact of the biotechnology revolution.
    MacGregor JT
    Toxicol Sci; 2003 Oct; 75(2):236-48. PubMed ID: 12883082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
    Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From -omics to personalized medicine in nephrology: integration is the key.
    Pesce F; Pathan S; Schena FP
    Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel omics technologies in nutrition research.
    Zhang X; Yap Y; Wei D; Chen G; Chen F
    Biotechnol Adv; 2008; 26(2):169-76. PubMed ID: 18164161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming omics data into context: bioinformatics on genomics and proteomics raw data.
    Perco P; Rapberger R; Siehs C; Lukas A; Oberbauer R; Mayer G; Mayer B
    Electrophoresis; 2006 Jul; 27(13):2659-75. PubMed ID: 16739231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer and the genomic revolution: Advances using microarray analyses.
    Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
    Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics, transcriptomics, proteomics, and numbers.
    Kiechle FL; Holland-Staley CA
    Arch Pathol Lab Med; 2003 Sep; 127(9):1089-97. PubMed ID: 12946210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging biomarker technologies.
    Gunn L; Smith MT
    IARC Sci Publ; 2004; (157):437-50. PubMed ID: 15055310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of technology in the clinical laboratory of the future.
    Wilkinson DS
    Clin Lab Manage Rev; 1997; 11(5):322-30. PubMed ID: 10175175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assigning functions to genes--the main challenge of the post-genomics era.
    Janitz M
    Rev Physiol Biochem Pharmacol; 2007; 159():115-29. PubMed ID: 17846923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Array-based proteomics: the latest chip challenge.
    Albala JS
    Expert Rev Mol Diagn; 2001 Jul; 1(2):145-52. PubMed ID: 11901809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of cDNA microarray analysis at the Genomic Medicine Research Core Laboratory (GMRCL) of Chang Gung Memorial Hospital.
    Wang TH; Lee YS; Chen ES; Kong WH; Chen LK; Hsueh DW; Wei ML; Wang HS; Lee YS
    Chang Gung Med J; 2004 Apr; 27(4):243-60. PubMed ID: 15239191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput genomic and proteomic technologies in the fight against infectious diseases.
    Tanca A; Deligios M; Addis MF; Uzzau S
    J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.